NCT01700842View on ClinicalTrials.gov

Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia

CompletedOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Bacterial Skin Diseases
Trial Locations (2)

Unknown

Research Site, Saint Petersburg

Research Site, Smolensk

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY